The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Drug-Induced Long QT Syndrome
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,423
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., VanRaay, T. J., Shen, J., Timothy, K. W., Vincent, G. M., de Jager, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0196-17 · Cited by 1,759
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Wang, Q., Shen, J., Splawski, I., Atkinson, D., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,686
Jervell, A., & Lange-Nielsen, F. (1957) · American Heart Journal · doi:10.1016/0002-8703(57)90079-0 · Cited by 1,596
CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P. J., Joseph, R. M., Condouris, K., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.011 · Cited by 1,586
Sanguinetti, M. C., & Jurkiewicz, N. K. (1990) · The Journal of general physiology · doi:10.1085/jgp.96.1.195 · Cited by 1,457
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
Genome-wide association study identifies eight loci associated with blood pressure
Wellcome Trust Case Control Consortium, Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J. H., Heath, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.361 · Cited by 1,215
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C., Møller, M., Bloch-Thomsen, P. E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken
FRIDERICIA, L. S. (1920) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1920.tb18266.x · Cited by 1,000
Plaster, N. M., Tawil, R., Tristani-Firouzi, M., Canún, S., Bendahhou, S., Tsunoda, A., Donaldson, M. R., Iannaccone, S. T., Brunt, E., Barohn, R., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00342-7 · Cited by 995
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
Mohler, P. J., Schott, J.-J., Gramolini, A. O., Dilly, K. W., Guatimosim, S., duBell, W. H., Song, L.-S., Haurogné, K., Kyndt, F., Ali, M. E., et al. (2003) · Nature · doi:10.1038/nature01335 · Cited by 957
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN.
Ward, O. C. (1964) · PubMed · Cited by 826
Cellular Basis for the Electrocardiographic J Wave
Yan, G.-X., & Antzelevitch, C. (1996) · Circulation · doi:10.1161/01.cir.93.2.372 · Cited by 812
Low Penetrance in the Long-QT Syndrome: Clinical Impact
Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 804
Mutations in the hminK gene cause long QT syndrome and suppress lKs function
Splawski, I., Tristani-Firouzi, M., Lehmann, M. H., Sanguinetti, M. C., & Keating, M. T. (1997) · Nature Genetics · doi:10.1038/ng1197-338 · Cited by 769
QT interval prolongation as predictor of sudden death in patients with myocardial infarction.
Schwartz, P. J., & Wolf, S. (1978) · Circulation · doi:10.1161/01.cir.57.6.1074 · Cited by 753
Antzelevitch, C., Sicouri, S., Litovsky, S. H., Lukas, A., Krishnan, S. C., Di Diego, J. M., Gintant, G. A., & Liu, D. W. (1991) · Circulation Research · doi:10.1161/01.res.69.6.1427 · Cited by 734
An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)
Sagie, A., Larson, M. G., Goldberg, R. J., Bengtson, J. R., & Levy, D. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90562-d · Cited by 715
Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.
January, C. T., & Riddle, J. M. (1989) · Circulation Research · doi:10.1161/01.res.64.5.977 · Cited by 673
Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes
RODEN, D. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00148.x · Cited by 667
Self-citationTorsades de Pointes Occurring in Association With Terfenadine Use
Monahan, B. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450210088038 · Cited by 667
Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences
Honig, P. K. (1993) · JAMA · doi:10.1001/jama.1993.03500120051025 · Cited by 664
Mechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
Sex differences in the evolution of the electrocardiographic QT interval with age.
Rautaharju, P. M., Sh, Z., Wong, S., Hp, C., Berenson, G. S., Prineas, R., & Davignon, A. (1992) · PubMed · Cited by 635
Treatment of torsade de pointes with magnesium sulfate.
Tzivoni, D., Banai, S., Schuger, C., Benhorin, J., Keren, A., Gottlieb, S., & Stern, S. (1988) · Circulation · doi:10.1161/01.cir.77.2.392 · Cited by 614
Liu, D.-W., & Antzelevitch, C. (1995) · Circulation Research · doi:10.1161/01.res.76.3.351 · Cited by 609
SELZER, A., & WRAY, H. W. (1964) · Circulation · doi:10.1161/01.cir.30.1.17 · Cited by 562
Mutant Caveolin-3 Induces Persistent Late Sodium Current and Is Associated With Long-QT Syndrome
Vatta, M., Ackerman, M. J., Ye, B., Makielski, J. C., Ughanze, E. E., Taylor, E. W., Tester, D. J., Balijepalli, R. C., Foell, J. D., Li, Z., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.635268 · Cited by 556
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 554
Self-citationA common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization
Arking, D. E., Pfeufer, A., Post, W., Kao, W. H. L., Newton-Cheh, C., Ikeda, M., West, K., Kashuk, C., Akyol, M., Perz, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1790 · Cited by 537
Hondeghem, L. M., Carlsson, L., & Duker, G. (2001) · Circulation · doi:10.1161/01.cir.103.15.2004 · Cited by 497
Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 488
Self-citationClinical relevance of cardiac arrhythmias generated by afterdepolarizations
Antzelevitch, C., & Sicouri, S. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90529-0 · Cited by 486
Stambler, B. S., Wood, M. A., Ellenbogen, K. A., Perry, K. T., Wakefield, L. K., & VanderLugt, J. T. (1996) · Circulation · doi:10.1161/01.cir.94.7.1613 · Cited by 486
Haverkamp*, W. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00119-x · Cited by 486
A common polymorphism associated with antibiotic-induced cardiac arrhythmia
Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L., & Goldstein, S. A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180223197 · Cited by 479
Self-citationKCNE1 mutations cause Jervell and Lange-Nielsen syndrome
Schulze-Bahr, E., Wang, Q., Wedekind, H., Haverkamp, W., Chen, Q., Sun, Y., Ruble, C., Hördt, M., Towbin, J. A., Borggrefe, M., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-267 · Cited by 463
Neal Kay, G., Vance J., P., Joaquin G., A., Richard W., H., & Albert L., W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463
Luo, S., Michler, K., Johnston, P., & Macfarlane, P. W. (2004) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2004.08.030 · Cited by 454
Yan, G.-X., Shimizu, W., & Antzelevitch, C. (1998) · Circulation · doi:10.1161/01.cir.98.18.1921 · Cited by 451
Malik, M., Färbom, P., Batchvarov, V, Hnatkova, K., & Camm, A. J. (2002) · Heart · doi:10.1136/heart.87.3.220 · Cited by 436
Yang, T., & Roden, D. M. (1996) · Circulation · doi:10.1161/01.cir.93.3.407 · Cited by 429
Self-citationTorsade de Pointes Associated with Very-High-Dose Methadone
Krantz, M. J., Lewkowiez, L., Hays, H., Woodroffe, M. A., Robertson, A. D., & Mehler, P. S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00010 · Cited by 426
[Ventricular tachycardia with 2 variable opposing foci].
Dessertenne, F. (1966) · PubMed · Cited by 414
Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism
Anderson, C. L., Delisle, B. P., Anson, B. D., Kilby, J. A., Will, M. L., Tester, D. J., Gong, Q., Zhou, Z., Ackerman, M. J., & January, C. T. (2006) · Circulation · doi:10.1161/circulationaha.105.570200 · Cited by 408
Jost, N., Virág, L., Bitay, M., Takács, J., Lengyel, C., Biliczki, P., Nagy, Z., Bogáts, G., Lathrop, D. A., Papp, J. G., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.550111 · Cited by 397
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Wilke, R. A., Lin, D. W., Roden, D. M., Watkins, P. B., Flockhart, D., Zineh, I., Giacomini, K. M., & Krauss, R. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2423 · Cited by 391
Self-citationCommon variants at ten loci modulate the QT interval duration in the QTSCD Study
Pfeufer, A., Sanna, S., Arking, D. E., Müller, M., Gateva, V., Fuchsberger, C., Ehret, G. B., Orrú, M., Pattaro, C., Köttgen, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.362 · Cited by 389
Honig, P. K., Woosley, R. L., Zamani, K., Conner, D. P., & Cantilena, L. R. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.135 · Cited by 367
Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels
Zhang, S., Zhou, Z., Gong, Q., Makielski, J. C., & January, C. T. (1999) · Circulation Research · doi:10.1161/01.res.84.9.989 · Cited by 366
SCN4B -Encoded Sodium Channel β4 Subunit in Congenital Long-QT Syndrome
Medeiros-Domingo, A., Kaku, T., Tester, D. J., Iturralde-Torres, P., Itty, A., Ye, B., Valdivia, C., Ueda, K., Canizales-Quinteros, S., Tusié-Luna, M. T., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.659086 · Cited by 363
KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome
Donger, C., Denjoy, I., Berthet, M., Neyroud, N., Cruaud, C., Bennaceur, M., Chivoret, G., Schwartz, K., Coumel, P., & Guicheney, P. (1997) · Circulation · doi:10.1161/01.cir.96.9.2778 · Cited by 348
Drug‐Induced Torsades de Pointes and Implications for Drug Development
FENICHEL, R. R., MALIK, M., ANTZELEVITCH, C., SANGUINETTI, M., RODEN, D. M., PRIORI, S. G., RUSKIN, J. N., LIPICKY, R. J., CANTILENA, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 346
Self-citationCardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia
Wang, Q., Shen, J., Li, Z., Timothy, K., Vincent, G. M., Priori, S. G., Schwartz, P. J., & Keating, M. T. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.9.1603 · Cited by 342
Roden, D. M., & Hoffman, B. F. (1985) · Circulation Research · doi:10.1161/01.res.56.6.857 · Cited by 340
Self-citationMutation of an A-kinase-anchoring protein causes long-QT syndrome
Chen, L., Marquardt, M. L., Tester, D. J., Sampson, K. J., Ackerman, M. J., & Kass, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710527105 · Cited by 336
Electrical heterogeneity within the ventricular wall
Antzelevitch, C., & Fish, J. (2001) · Basic Research in Cardiology · doi:10.1007/s003950170002 · Cited by 334
Ueda, K., Valdivia, C., Medeiros-Domingo, A., Tester, D. J., Vatta, M., Farrugia, G., Ackerman, M. J., & Makielski, J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801294105 · Cited by 326
NAPOLITANO, C., SCHWARTZ, P. J., BROWN, A. M., RONCHETTI, E., BIANCHI, L., PINNAVAIA, A., ACQUARO, G., & PRIORI, S. G. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00033.x · Cited by 300
The hERG potassium channel and hERG screening for drug-induced torsades de pointes
Hancox, J. C., McPate, M. J., El Harchi, A., & Zhang, Y. H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.009 · Cited by 299
Prolonged QT interval predicts cardiac and all-cause mortality in the elderly The Rotterdam Study
de Bruyne, M. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1276 · Cited by 298
Mechanisms of Arsenic-Induced Prolongation of Cardiac Repolarization
Ficker, E., Kuryshev, Y. A., Dennis, A. T., Obejero-Paz, C., Wang, L., Hawryluk, P., Wible, B. A., & Brown, A. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.33 · Cited by 286
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype
Zareba, W., Moss, A. J., Locati, E. H., Lehmann, M. H., Peterson, D. R., Hall, W. J., Schwartz, P. J., Vincent, G. M., Priori, S. G., Benhorin, J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00554-0 · Cited by 283
Paulussen, A. D. C., Gilissen, R. A. H. J., Armstrong, M., Doevendans, P. A., Verhasselt, P., Smeets, H. J. M., Schulze-Bahr, E., Haverkamp, W., Breithardt, G., Cohen, N., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0522-z · Cited by 280
Opthof, T., Coronel, R., Wilms-Schopman, F. J. G., Plotnikov, A. N., Shlapakova, I. N., Danilo, P., Rosen, M. R., & Janse, M. J. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2006.11.022 · Cited by 278
Physicochemical Features of the hERG Channel Drug Binding Site
Fernandez, D., Ghanta, A., Kauffman, G. W., & Sanguinetti, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310683200 · Cited by 266
Karjalainen, J., Viitasalo, M., Mänttäri, M., & Manninen, V. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90654-8 · Cited by 264
Sipido, K. R., Volders, P. G. A., de Groot, S. H. M., Verdonck, F., Van de Werf, F., Wellens, H. J. J., & Vos, M. A. (2000) · Circulation · doi:10.1161/01.cir.102.17.2137 · Cited by 263
Reant, P., Lafitte, S., Jaïs, P., Serri, K., Weerasooriya, R., Hocini, M., Pillois, X., Clementy, J., Haïssaguerre, M., & Roudaut, R. (2005) · Circulation · doi:10.1161/circulationaha.104.523928 · Cited by 262
Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking
Kuryshev, Y. A., Ficker, E., Wang, L., Hawryluk, P., Dennis, A. T., Wible, B. A., Brown, A. M., Kang, J., Chen, X.-L., Sawamura, K., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073692 · Cited by 258
Genetics of acquired long QT syndrome
Roden, D. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25539 · Cited by 256
Self-citationEap, C. B., Crettol, S., Rougier, J.-S., Schläpfer, J., Sintra Grilo, L., Déglon, J.-J., Besson, J., Croquette-Krokar, M., Carrupt, P.-A., & Abriel, H. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100120 · Cited by 255
Romano, C., Gemme, G., & Pongiglione, R. (1963) · PubMed · Cited by 254
Zygmunt, A. C., Eddlestone, G. T., Thomas, G. P., Nesterenko, V. V., & Antzelevitch, C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.2.h689 · Cited by 254
Vos, M. A., de Groot, S. H. M., Verduyn, S. C., van der Zande, J., Leunissen, H. D. M., Cleutjens, J. P. M., van Bilsen, M., Daemen, M. J. A. P., Schreuder, J. J., Allessie, M. A., et al. (1998) · Circulation · doi:10.1161/01.cir.98.11.1125 · Cited by 247
High affinity open channel block by dofetilide of HERG expressed in a human cell line.
Snyders, D. J., & Chaudhary, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09019-4 · Cited by 242
Electrophysiological and Beta-Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue
STRAUSS, H. C., BIGGER, J. T., & HOFFMAN, B. F. (1970) · Circulation Research · doi:10.1161/01.res.26.6.661 · Cited by 241
Chugh, S. S., Reinier, K., Singh, T., Uy-Evanado, A., Socoteanu, C., Peters, D., Mariani, R., Gunson, K., & Jui, J. (2009) · Circulation · doi:10.1161/circulationaha.108.797035 · Cited by 238
The Morphology of the QT Interval Predicts Torsade de Pointes During Acquired Bradyarrhythmias
Topilski, I., Rogowski, O., Rosso, R., Justo, D., Copperman, Y., Glikson, M., Belhassen, B., Hochenberg, M., & Viskin, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.058 · Cited by 236
Carlsson, L., Almgren, O., & Duker, G. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199008000-00014 · Cited by 235
ZHOU, Z., VORPERIAN, V. R., GONG, Q., ZHANG, S., & JANUARY, C. T. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00264.x · Cited by 234
Carlsson, L., Abrahamsson, C., Andersson, B., Duker, G., & Schiller-Linhardt, G. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2186 · Cited by 213
Silva, J., & Rudy, Y. (2005) · Circulation · doi:10.1161/circulationaha.105.543306 · Cited by 213
Gender Difference in the Cycle Length-Dependent QT and Potassium Currents in Rabbits
Liu, X.-K., Katchman, A., Drici, M.-D., Ebert, S. N., Ducic, I., Morad, M., & Woosley, R. L. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37435-x · Cited by 209
Refining detection of drug-induced proarrhythmia: QT interval and TRIaD
Shah, R. R., & Hondeghem, L. M. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.03.023 · Cited by 205
Hohnloser, S. H., van de Loo, A., & Baedeker, F. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00286-5 · Cited by 204
Identification of a Kir3.4 Mutation in Congenital Long QT Syndrome
Yang, Y., Yang, Y., Liang, B., Liu, J., Li, J., Grunnet, M., Olesen, S.-P., Rasmussen, H. B., Ellinor, P. T., Gao, L., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.04.017 · Cited by 200
Vos, M. A., Verduyn, S. C., Gorgels, A. P. M., Lipcsei, G. C., & Wellens, H. J. J. (1995) · Circulation · doi:10.1161/01.cir.91.3.864 · Cited by 195
Rajamani, S., Eckhardt, L. L., Valdivia, C. R., Klemens, C. A., Gillman, B. M., Anderson, C. L., Holzem, K. M., Delisle, B. P., Anson, B. D., Makielski, J. C., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706892 · Cited by 193
Kao, W. H. L., Arking, D. E., Post, W., Rea, T. D., Sotoodehnia, N., Prineas, R. J., Bishe, B., Doan, B. Q., Boerwinkle, E., Psaty, B. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.791723 · Cited by 185
Increased Atrial Fibrillation Mortality: United States, 1980-1998
Wattigney, W. A. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.9.819 · Cited by 176
Yang, T., Snyders, D. J., & Roden, D. M. (1997) · Circulation Research · doi:10.1161/01.res.80.6.782 · Cited by 172
Self-citationDrug Block of I Kr : Model Systems and Relevance to Human Arrhythmias
Yang, T., Snyders, D., & Roden, D. M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200111000-00010 · Cited by 171
Self-citationCAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart
Chang, K., Barth, A. S., Sasano, T., Kizana, E., Kashiwakura, Y., Zhang, Y., Foster, D. B., & Marbán, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709118105 · Cited by 166
Mohler, P. J., Le Scouarnec, S., Denjoy, I., Lowe, J. S., Guicheney, P., Caron, L., Driskell, I. M., Schott, J.-J., Norris, K., Leenhardt, A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.656512 · Cited by 165
Self-citationSudden Death During Treatment With Phenothiazine Derivatives
Hollister, L. E. (1965) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1965.03080250013003 · Cited by 164
Shimizu, W., Ohe, T., Kurita, T., Kawade, M., Arakaki, Y., Aihara, N., Kamakura, S., Kamiya, T., & Shimomura, K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00313-4 · Cited by 164
Cardiotoxic effect with convulsions in terfenadine overdose.
Davies, A. J., Harindra, V., McEwan, A., & Ghose, R. R. (1989) · BMJ · doi:10.1136/bmj.298.6669.325 · Cited by 164
WEISSENBURGER, J., Nesterenko, V. V., & Antzelevitch, C. N. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb01798.x · Cited by 156
Clinical safety profile of sotalol in patients with arrhythmias
Soyka, L. F., Wirtz, C., & Spangenberg, R. B. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90207-h · Cited by 155
D85N, a KCNE1 Polymorphism, Is a Disease-Causing Gene Variant in Long QT Syndrome
Nishio, Y., Makiyama, T., Itoh, H., Sakaguchi, T., Ohno, S., Gong, Y.-Z., Yamamoto, S., Ozawa, T., Ding, W., Toyoda, F., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.005 · Cited by 155
Johnson, E. A., & McKinnon, M. (1957) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11872-7 · Cited by 152
The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT Studies
Bloomfield, D., Kost, J. T., Ghosh, K., Hreniuk, D., Hickey, L., Guitierrez, M., Gottesdiener, K. M., & Wagner, J. A. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.33 · Cited by 151
Kurita, T., Ohe, T., Marui, N., Aihara, N., Takaki, H., KAMAKURA, S., Matsuhisa, M., & Shimomura, K. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90154-q · Cited by 147
Pratt, C. M., Ruberg, S. J., Morganroth, J., McNutt, B. E., Woodward, J. K., Harris, S. I., Ruskin, J. N., & Moyé, L. A. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90525-6 · Cited by 143
Rajamani, S., Anderson, C. L., Anson, B. D., & January, C. T. (2002) · Circulation · doi:10.1161/01.cir.0000019513.50928.74 · Cited by 138
Shimizu, W., McMAHON, B., & Antzelevitch, C. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00656.x · Cited by 133
Hondeghem, L. M., & Hoffmann, P. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200301000-00003 · Cited by 133
Lengyel, C., Varró, A., Tábori, K., Papp, J. G., & Baczkó, I. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707297 · Cited by 131
Pentamidine reduces hERG expression to prolong the QT interval
Cordes, J. S., Sun, Z., Lloyd, D. B., Bradley, J. A., Opsahl, A., Tengowski, M. W., Chen, X., & Zhou, J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706140 · Cited by 128
Sotalol: An important new antiarrhythmic
Anderson, J. L., & Prystowsky, E. N. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70484-9 · Cited by 127
Acceleration‐Induced Action Potential Prolongation and Early Afterdepolarizations
Burashnikov, A., & Antzelevitch, C. N. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00134.x · Cited by 125
Cardiac Sodium Channel Gene Variants and Sudden Cardiac Death in Women
Albert, C. M., Nam, E. G., Rimm, E. B., Jin, H. W., Hajjar, R. J., Hunter, D. J., MacRae, C. A., & Ellinor, P. T. (2007) · Circulation · doi:10.1161/circulationaha.107.736330 · Cited by 124
Antiarrhythmic drugs and torsade de pointes
Lazzara, R. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.suppl_h.88 · Cited by 118
Thomas, D., Gut, B., Wendt‐Nordahl, G., & Kiehn, J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.543 · Cited by 117
Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil
Aiba, T., Shimizu, W., Inagaki, M., Noda, T., Miyoshi, S., Ding, W., Zankov, D. P., Toyoda, F., Matsuura, H., Horie, M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.069 · Cited by 116
Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome
Kirchhof, P., Franz, M. R., Bardai, A., & Wilde, A. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.043 · Cited by 112 · cited 2×
“…major effects that could, in theory, promote TdP: 1) there is striking deformity of the pause after the QT interval, often with the development of a large U-wave (Viskin et al., 2004; Topilski et al., 2007; Kirchhof et al., 2009), suggesting a role for afterdepolarizations discussed in section II.”
BackgroundMilan, D. J., Kim, A. M., Winterfield, J. R., Jones, I. L., Pfeufer, A., Sanna, S., Arking, D. E., Amsterdam, A., Sabeh, K., Mably, J. D., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.821082 · Cited by 111
Self-citationCalmodulin Kinase Inhibition Prevents Development of the Arrhythmogenic Transient Inward Current
Wu, Y., Roden, D. M., & Anderson, M. E. (1999) · Circulation Research · doi:10.1161/01.res.84.8.906 · Cited by 110
Self-citationGuo, J. X., Massaeli, H., Li, W., Xu, J., Luo, T., Shaw, J., Kirshenbaum, L. A., & Zhang, S. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120931 · Cited by 110
Use of Terfenadine and Contraindicated Drugs
Thompson, D. (1996) · JAMA · doi:10.1001/jama.1996.03530410053033 · Cited by 109
Thomsen, M. B., Oros, A., Schoenmakers, M., VANOPSTAL, J., MAAS, J., Beekman, J. D. M., & Vos, M. A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.025 · Cited by 108
Pharmacies and Prevention of Potentially Fatal Drug Interactions
Cavuto, N. J., Woosley, R. L., & Sale, M. (1996) · JAMA · doi:10.1001/jama.1996.03530380028022 · Cited by 107
Protecting the Heart Against Arrhythmias: Potassium Current Physiology and Repolarization Reserve
Roden, D. M., & Yang, T. (2005) · Circulation · doi:10.1161/circulationaha.105.562777 · Cited by 105
Self-citationTorsade De Pointes Induced by Cisapride/Clarithromycin Interaction
Piquette, R. K. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18107 · Cited by 103
Wu, L., Shryock, J. C., Song, Y., & Belardinelli, L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094862 · Cited by 100
Xiao, L., Xiao, J., Luo, X., Lin, H., Wang, Z., & Nattel, S. (2008) · Circulation · doi:10.1161/circulationaha.107.758672 · Cited by 99
The canine model with chronic, complete atrio-ventricular block
Oros, A., Beekman, J. D. M., & Vos, M. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.03.006 · Cited by 94
VORPERIAN, V. R., Zhou, Z., Mohammad, S., Hoon, T. J., Studenik, C. R., & January, C. T. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00352-x · Cited by 94
Amiodarone and Torsade de Pointes
Lazzara, R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-549 · Cited by 93
Drug-induced spatial dispersion of repolarization.
Antzelevitch, C. N. (2008) · PubMed · Cited by 92
Exaggerated QT prolongation after cardioversion of atrial fibrillation
Choy, A. M. J., Darbar, D., Dell’Orto, S., & Roden, D. M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00226-0 · Cited by 89
Self-citationThe risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada
Walker, A. M., Szneke, P., Weatherby, L. B., DICKER, L. W., Lanza, L. L., Loughlin, J. E., Yee, C. L., & Dreyer, N. A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00241-7 · Cited by 88
Lawrence, C., Bridgland-Taylor, M. H., Pollard, C. E., Hammond, T. G., & Valentin, J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706894 · Cited by 86
Drug-induced torsades de pointes: The evolving role of pharmacogenetics
Fitzgerald, P., & Ackerman, M. J. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.08.007 · Cited by 85
Kannankeril, P. J., Roden, D. M., NORRIS, K. J., Whalen, S. P., George, A. L., & Murray, K. T. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2004.10.039 · Cited by 84
Self-citationHondeghem, L. M. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00347.x · Cited by 82
Thomsen, M. B., Beekman, J. D. M., Attevelt, N. J. M., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706900 · Cited by 81
Gintant, G. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.010 · Cited by 81
Pollard, C. E., Valentin, J., & Tg, H. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.203 · Cited by 76
Death associated with ventricular arrhythmia and thioridazine hydrochloride.
Giles, T. D., & Modlin, R. K. (1968) · PubMed · Cited by 75
El‐Sherif, N., Caref, E. B., Chinushi, M., & Restivo, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00700-1 · Cited by 74
Milberg, P., Reinsch, N., Osada, N., Wasmer, K., Mönnig, G., Stypmann, J., Breithardt, G., Haverkamp, W., & Eckardt, L. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0533-8 · Cited by 67
Torsade de pointes ventricular tachycardia associated with astemizole overdose
Snook, J. A., Boothman‐Burrell, D., Watkins, J., et al. (1988) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1988.tb08578.x · Cited by 67
Drug‐Induced QT Interval Prolongation—Regulatory Guidance and Perspectives on hERG Channel Studies
Shah, R. R. (2005) · Novartis Foundation symposium · doi:10.1002/047002142x.ch19 · Cited by 66
Abrahamsson, C., Palmer, M. D., Ljung, B., Duker, G., Bäärnhielm, C., Carlsson, L. M. S., & Danielsson, B. R. G. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.3.337 · Cited by 65
Drug-induced long QT syndrome in women: Review of current evidence and remaining gaps
Hreiche, R., Morissette, P., & Turgeon, J. (2008) · Gender Medicine · doi:10.1016/j.genm.2008.05.005 · Cited by 62
N-Acetyl procainamide causing torsades de pointes
Olshansky, B., Martins, J. B., & Hunt, S. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90489-1 · Cited by 60
Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease.
Buff, D. D., Brenner, R., Kirtane, S. S., & Gilboa, R. (1991) · PubMed · Cited by 59
van Opstal, J. M. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00226-7 · Cited by 59
Wang, D., Patel, C., Cui, C., & Yan, G. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.009 · Cited by 55
New Mechanism Contributing to Drug-Induced Arrhythmia
Liu, K., Yang, T., Viswanathan, P. C., & Roden, D. M. (2005) · Circulation · doi:10.1161/circulationaha.105.564008 · Cited by 55
Self-citationMank-Seymour, A. R., Richmond, J., Wood, L. S., Reynolds, J. M., Fan, Y.-T., Warnes, G. R., Milos, P. M., & Thompson, J. F. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.08.020 · Cited by 54
Magnesium treatment of ventricular arrhythmias
Roden, D. M. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90219-1 · Cited by 52
Self-citationSun, Z., THOMAS, G. P., & Antzelevitch, C. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00472.x · Cited by 52
Kuryshev, Y. A., Wang, L., Wible, B. A., Wan, X., & Ficker, E. K. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019281 · Cited by 50
Darbar, D., Kimbrough, J., Jawaid, A., McCray, R., Ritchie, M. D., & Roden, D. M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.066 · Cited by 49
Self-citationTorsade de pointes associated with moxifloxacin: A rare but potentially fatal adverse event
Altın, T., Özcan, Ö. U., Turhan, S., et al. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70850-4 · Cited by 48
Combined use of astemizole and ketoconazole resulting in torsade de pointes.
Tsai, W., Tsai, L., & Chen, J. (1997) · PubMed · Cited by 46
Drug Labeling Revisions—Guaranteed to Fail?
Woosley, R. L. (2000) · JAMA · doi:10.1001/jama.284.23.3047 · Cited by 45
Torsade de pointes induced by N-Acetylprocainamide
Chow, M. J., Piergies, A. A., Bowsher, D. J., Murphy, J. J., Kushner, W., Ruo, T. I., Asada, A., Talano, J. V., & Atkinson, A. J. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80111-4 · Cited by 44
Model systems for the discovery and development of antiarrhythmic drugs
Nattel, S., Duker, G., & Carlsson, L. G. (2008) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2008.10.009 · Cited by 43
The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes
Carlsson, L. G. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.004 · Cited by 42
The pause that refreshes, or does it? Mechanisms in torsades de pointes
Roden, D. M., & ANDERSON, M. E. (2000) · Heart · doi:10.1136/heart.84.3.235 · Cited by 40
Self-citationhERG (KCNH2 or Kv11.1) K+ Channels: Screening for Cardiac Arrhythmia Risk
Bowlby, M. R., Peri, R., Zhang, H., & Dunlop, J. (2008) · Current Drug Metabolism · doi:10.2174/138920008786485083 · Cited by 39
Observations on the onset of Torsade de Pointes arrhythmias in the acquired long QT syndrome
Vos, M. A. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00192-9 · Cited by 38
NovelKCNE3mutation reduces repolarizing potassium current and associated with long QT syndrome
Ohno, S., Toyoda, F., Zankov, D. P., Yoshida, H., Makiyama, T., Tsuji, K., Honda, T., Obayashi, K., Ueyama, H., Shimizu, W., et al. (2009) · Human Mutation · doi:10.1002/humu.20834 · Cited by 36
Sex Modulates the Arrhythmogenic Substrate in Prepubertal Rabbit Hearts with Long QT 2
LIU, T., Choi, B., Drici, M., & Salama, G. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2005.40622.x · Cited by 35
Burkhart, G. A., Sevka, M. J., Temple, R., & Honig, P. K. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90185-5 · Cited by 35
[The long QT syndrome and syncope caused by spike torsades].
Motté, G., Coumel, P., Abitbol, G., et al. (1970) · PubMed · Cited by 35
Moxifloxacin-induced torsades de pointes.
Sherazi, S., DiSalle, M. R., Daubert, J. P., & Shah, A. H. (2008) · PubMed · Cited by 34
Gender‐Related Differences in Ventricular Repolarization: Beyond Gonadal Steroids
Arya, A. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.40845.x · Cited by 33
Cheng, H. C., & Incardona, J. (2009) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2009.05.010 · Cited by 33
Becker, M. L., Visser, L. E., Newton‐Cheh, C., Albert Hofman, D., Uitterlinden, A. G., Witteman, J. C. M., & Stricker, B. H. C. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03325.x · Cited by 31
Near‐Thorough QT Study as Part of a First‐In‐Man Study
Malík, M., Hnatkova, K., Ford, J., et al. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008323261 · Cited by 30
Reiffel, J. A., & Appel, G. B. (2001) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840100600202 · Cited by 24
When U Say “U Waves,” What Do U Mean?
Viskin, S., Zeltser, D., & Antzelevitch, C. N. (2004) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2004.00403.x · Cited by 21
An Underrecognized Challenge in Evaluating Postmarketing Drug Safety
Roden, D. M. (2005) · Circulation · doi:10.1161/01.cir.0000154578.45378.8c · Cited by 20
Self-citationDelayed Sodium Channel Inactivation Mimics Long QT Syndrome 3
Kühlkamp, V., Mewis, C., BOSCH, R. F., & Seipel, L. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200307000-00017 · Cited by 17
Proarrhythmic effects of a quinidine analog in dogs with chronic A‐V block
Chézalviel, F., WEISSENBURGER, J., Davy, J., Guhennec, C., Poirier, J., & CHEYMOL, G. (1995) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00291.x · Cited by 14
Use of in vitro methods to predict QT prolongation
Hammond, T. G., & POLLARD, C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.03.022 · Cited by 12
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Metadata
- Authors
- Kannankeril, P., Roden, D. M., & Darbar, D.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 62
- Issue
- 4
- Pages
- 760-781
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2159808944
- Cited by
- 440
- References
- 186
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.